drugset / Trial / NCT00967148

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

NCT00967148

RandomizedParallel-groupOpen-labelPrevention

Summary

The blood thinner "tinzaparin" might increase survival in patients with colon cancer undergoing surgical resection. The investigators want to assess if a trial allocating patients to prolonged treatment with tinzaparin versus standard of care is feasible.

Timeline

Start
2009-06
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tinzaparin Other / unclassified 4500 iu Subcutaneous